pRM055 His-TEV-Cas9 6xNLS 0C
(Plasmid
#196246)
-
PurposeExpression of NLS-rich Cas9 (0 Cys residues, mammalian codon optimized)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 196246 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepML-2CT
-
Backbone manufacturerMacrolab, UC Berkeley
- Backbone size w/o insert (bp) 5950
- Total vector size (bp) 9111
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCas9
-
Alt nameCas9-6xNLS
-
SpeciesStreptococcus pyogenes
-
Insert Size (bp)4103
- Promoter T7
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer T7 promoter
- 3′ sequencing primer T7 terminator (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made by4xNLS-pMJ915v2 from Jennifer Doudna (Addgene plasmid # 88917 ; http://n2t.net/addgene:88917 ; RRID:Addgene_88917)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRM055 His-TEV-Cas9 6xNLS 0C was a gift from Ross Wilson (Addgene plasmid # 196246 ; http://n2t.net/addgene:196246 ; RRID:Addgene_196246) -
For your References section:
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes. Foss DV, Muldoon JJ, Nguyen DN, Carr D, Sahu SU, Hunsinger JM, Wyman SK, Krishnappa N, Mendonsa R, Schanzer EV, Shy BR, Vykunta VS, Allain V, Li Z, Marson A, Eyquem J, Wilson RC. Nat Biomed Eng. 2023 May;7(5):647-660. doi: 10.1038/s41551-023-01032-2. Epub 2023 Apr 25. 10.1038/s41551-023-01032-2 PubMed 37147433